VNS Therapy works to provide fewer seizures, shorter seizures
and an improved recovery after seizures.

Investor Relations

investor.relations@livanova.com

corporate.communications@livanova.com

Customer Support

1-866-332-1375

(If you are an implanted patient and need a replacement VNS Therapy Patient Emergency Information Card, please contact Customer Support)

Epilepsy (Non-US)—The VNS Therapy System is indicated for use as an adjunctive therapy in reducing the frequency of seizures in patients whose epileptic disorder is dominated by partial seizures (with or without secondary generalization) or generalized seizures that are refractory to seizure medications. Model 106 AspireSR™ (Seizure Response) features the Automatic Stimulation Mode which is intended for patients who experience seizures that are associated with cardiac rhythm increases known as ictal tachycardia.

Epilepsy (US)--The VNS Therapy System is indicated for use as an adjunctive therapy in reducing the frequency of seizures in patients 4 years of age and older with partial onset seizures that are refractory to antiepileptic medications.Commonly reported side effects are hoarseness, shortness of breath, sore throat and coughing. Side effects typically occur during stimulation and decrease over time. Download the appropriate country product information above for important safety information.